| P50 | author | Brian W Pogue | Q38319770 |
| P2093 | author name string | Kimberley S Samkoe | |
| | P Jack Hoopes | |
| | Jason Gunn | |
| | Kenneth Tichauer | |
| | Kristian Sexton | |
| P2860 | cites work | Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients | Q30634636 |
| | Engineering novel binding proteins from nonimmunoglobulin domains | Q33224761 |
| | Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance | Q33285819 |
| | Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule | Q33315521 |
| | Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker | Q33856249 |
| | Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model | Q33872581 |
| | Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article | Q34063357 |
| | Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification | Q34350623 |
| | Epidermal growth factor receptor biology (IMC-C225). | Q34416870 |
| | Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial | Q34519250 |
| | Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm | Q34632917 |
| | Engineered antibody fragments and the rise of single domains | Q34650980 |
| | The clinical use of fluorescein in neurosurgery; the localization of brain tumors | Q34854212 |
| | Combined fluorescence and reflectance spectroscopy for in vivo quantification of cancer biomarkers in low- and high-grade glioma surgery | Q35566187 |
| | A structure-based model for ligand binding and dimerization of EGF receptors | Q35730035 |
| | Porphyrin metabolism in some malignant diseases | Q35993568 |
| | Quantitative, spectrally-resolved intraoperative fluorescence imaging | Q36397667 |
| | High vascular delivery of EGF, but low receptor binding rate is observed in AsPC-1 tumors as compared to normal pancreas. | Q36485041 |
| | The biological properties of cetuximab | Q37233886 |
| | Diagnostic detection of diffuse glioma tumors in vive with molecular fluorescent probe-based transmission spectroscopy | Q37330479 |
| | The EGF receptor system as a target for antitumor therapy | Q37427689 |
| | Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. | Q37730252 |
| | Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier | Q37819809 |
| | Pathophysiology of heme synthesis | Q39556839 |
| | Detecting epidermal growth factor receptor tumor activity in vivo during cetuximab therapy of murine gliomas | Q39792678 |
| | Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry | Q39891849 |
| | Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule | Q40091707 |
| | Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma. | Q41522434 |
| | Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature | Q41822458 |
| | Positive progress in immunoPET--not just a coincidence | Q42429164 |
| | In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. | Q42465800 |
| | Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note | Q44575676 |
| | Fluorescence-guided resections of malignant gliomas--an overview | Q44609596 |
| | Diffusion of epidermal growth factor in rat brain extracellular space measured by integrative optical imaging | Q44989724 |
| | Intraoperative navigation and fluorescence imagings in malignant glioma surgery | Q46317102 |
| | Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias | Q46634561 |
| | Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect | Q48186495 |
| | Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome | Q48291994 |
| | Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin | Q48536258 |
| | Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts | Q48797418 |
| | Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas | Q49044640 |
| | Comparison of methods for analysis of clinical [11C]raclopride studies. | Q52320706 |
| | Plasma drug concentrations: description and interpretation of the biexponential decay. | Q52387208 |
| | Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. | Q55480724 |
| | Indocyanine green (ICG) staining and demarcation of tumor margins in a rat glioma model | Q55482574 |
| | Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model | Q77555291 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | e60390 | |
| P577 | publication date | 2013-04-12 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Fluorescent affibody peptide penetration in glioma margin is superior to full antibody | |
| P478 | volume | 8 | |